0 %

Our NEO-M-200 robotic system is designed to provide fully automated, high-efficiency sample processing, ensuring precision, reliability, and reproducibility at every step. From sample lysis to reagent buffer distribution, our protocol optimizes automation for seamless and consistent results.

Key Features

icon fast
Ensures optimal sample preparation conditions
icon convenient
Preserves reagent stability throughout the process
icon flexibility
Processes up to two plates
icon user-friendly
Tracks every step for enhanced compliance and reliability

Compatible assays

LaCar
The NEONATAL SCID&SMA Screening qPCR Flex kit is an assay intended for the semi-quantitative determination of TREC, aiding in the screening of newborns for Severe Combined Immunodeficiency (SCID), and for the qualitative detection of the SMN1 gene (Exon 7), aiding in the screening of newborns for Spinal Muscular Atrophy (SMA).

Research and Development

Our vision

At LaCAR, we envision a world where everyone benefits from rapid and reliable genetic diagnostics, enabling personalised healthcare while contributing to more equitable and sustainable global public health.

Aware of these challenges, our R&D team is committed to meeting the needs of customers and patients, taking into account the specific recommendations of different countries and continents, as well as advances in academic research and technology.

You have a question regarding our products ? You want to know more about our method ?

Contact